Browsing Category

Compliance & Safety

Blood Bank, Compliance & Safety, Corewell Health System

Reminder Pre‑Surgical Type & Screen Orders

When ordering a Pre‑surgical Type & Screen, all required order questions must be completed accurately. These answers drive specimen routing, collection timing, and blood bank workflow in Epic.

Epic uses your responses to ensure testing is performed by the correct blood bank at the correct time. Incomplete or incorrect information can result in misrouted specimens, delays, rework, or redraws.

Providers must accurately complete:

  • Reason for ordering (surgery, procedure, transfusion, L&D)
  • Procedure location
  • Date of procedure
  • Recent transfusion or pregnancy history

Key location clarification (West Michigan)

  • BW/HDVCH/LHCP/MHC refers to Butterworth Hospital, Helen DeVos Children’s Hospital, Lemmen Holton Cancer Pavilion, and Meijer Heart Center and is NOT the same as Blodgett Hospital located in East Grand Rapids.
  • These are distinct locations in Epic and route to different blood banks (Blodgett Blood Bank vs. Butterworth Blood Bank)

Why it matters

Incorrect or incomplete responses can lead to:

  • Delayed pre‑op testing
  • Extra time spent clarifying procedure details
  • Specimens sent to the wrong blood bank
  • Frustration for lab and clinical teams

Takeaway

  • Answer all Type & Screen order questions carefully
  • Select the exact facility where the procedure will occur
  • Avoid defaults or outdated favorites

Taking a few extra seconds to review these fields helps ensure timely testing and smoother pre‑surgical care.

Epic Care Teams: Please review “Orders – Type & Screen Ordering for Surgery/Procedure (Pre-surgical blood type specimen)” in Epic Education on SharePoint for detailed information.

Compliance & Safety, Southwest Michigan, West Michigan

Lab Catalog URL Update – Action Required by December 31, 2025

Effective December 31, 2025, the URL corewellhealth.testcatalog.org will be discontinued.
There will be no automatic redirect to the new site.

To avoid disruption of service, please update your saved links or browser favorites for the Lab Catalog (also known as the Lab Test Directory) to:

👉 corewellhealth.org/labcatalog

This landing page allows you to select the appropriate region for you or your patient’s specimen and will always direct you to the most up-to-date catalog URL for your area.

Update your bookmarks today to ensure uninterrupted access to lab testing information.

Compliance & Safety

Inclusion of a Third Patient Identifier on Paper-Based Orders to Increase Safety

To enhance patient safety, we are implementing a requirement for paper-based orders to include a minimum of three patient identifiers.

Effective June 30, 2025, all paper-based orders (including add-on orders) must include at least three patient identifiers. Patient’s Legal Name and Date of Birth must match the ones on the specimen’s label, and the third must match the identifier in the Electronic Health Record (EHR). Any extra identifiers on the specimen label must also match the ones on the paperwork and in the EHR.

Continue Reading

Compliance & Safety

Anti-TPO Assay Falsely Elevated Recovery

A reagent bulletin from Roche has informed us that the recovery of the Anti-TPO assay has been falsely elevated for a reagent lot that was in use at Corewell Health Grand Rapids from September 2024 until March, 3, 2025. Based on the product evaluation, and in conjunction with a product and safety risk assessment, the remaining risk of false positive results with the Elecsys Anti-TPO assay is in the acceptable range.

We apologize for the inconvenience. Please reach out with any concerns or questions.

Best,

Dr. Alvarez
Yasel Alvarez, Ph.D.
Clinical Chemistry and Immunology
Corewell Health Reference Laboratory, West Michigan

Test Information

Thyroid Peroxidase Antibody, Blood Level [LAB516]

Clinical Implications

The risk of false positive results with the Elecsys anti-TPO assay is generally acceptable with respect to the given discrepancy.

Resources

Roche Customer Bulletin TP-02316

Compliance & Safety, General Information, Referral/Sendouts

Weather Impact on Send Out Testing

We want to inform you about an important update regarding T-Spot test collections and deliveries. Due to severe weather conditions expected to affect parts of the United States, we have been advised by our reference laboratory to suspend the collection and sending of this test on Monday, February 17 after 3 p.m. through Tuesday, February 18. Testing collection will begin again on Wednesday, February 19th, unless the request is extended.

This precaution is necessary to ensure the safety and integrity of the specimens, as well as to avoid any potential delays or issues that could arise from the adverse weather. We appreciate your understanding and cooperation during this time.

Compliance & Safety, Education & Training, General Information

Updated Advanced Beneficiary (ABN) Statuses (Corewell Health Epic Users)

On Tuesday, Jan. 7, you will see changes to the ABN Status list in Epic, making it easier to select the appropriate status from available options.

In an effort to optimize workflows, the ABN statuses in Epic have been changed to be more efficient. Some statuses have been removed based on volume of use and feedback from clinicians. Other options have been changed to ensure clarity after review by Informatics, Compliance, and Revenue Cycle. The information below lists the new options and when to use them. Please refer to Epic Proportions for more information.

Attention providers: to reduce your ABN workflow burden, please select one of the first two Provider ABN statuses at the time of order entry only. The collection of signed ABN waivers will occur later by office, laboratory, or imaging staff using the three ABN Signed statuses when the specimen is being collected or when the imaging procedure is being performed. If your office routinely collects laboratory specimens, please instruct your staff to collect ABN signature waiver at the time of specimen collection.

Status Options Available after January 7, 2025:

  • Provider: ABN Discussed. Await Signature. [205] = Providers placing orders when the patient is present to discuss ABN, select this option. This allows the provider to place the order while also allowing lab or radiology staff the ability to complete their process as usual later and avoid the need for a new order. Patient will sign during lab/imaging procedure.
  • Provider: ABN Not Discussed. Patient Not Present. [206] = Providers placing orders when the patient is not available or present, select this option. This allows the provider to place the order while also allowing lab or radiology staff the ability to complete their process as usual later and avoid the need for a new order. Lab/imaging will need to discuss ABN and sign.
  • ABN Signed, Service Accepted (Option 1 – Bill Medicare) [3] = This status indicates that a patient has signed the form, wants to receive the service, and agrees to be financially responsible for the service if Medicare does not pay. This option should only be used by the person who is presenting the ABN to the patient for signature.
  • ABN Signed, Service Accepted (Option 2 – Do not Bill Medicare) [9] = This status indicates that a patient has signed the form, wants to receive the service, agrees to be financially responsible for the service, and agrees not to bill Medicare. This option should only be used by the person who is presenting the ABN to the patient for signature.
  • ABN Signed, Service Declined [6] = This status indicates that a patient has signed the form and does not want to receive the service. Typically, the clinician cancels the order in this situation. If a patient signs the form and declines the service but the physician believes it is important to proceed with the service at Corewell Health’ expense the test should not be canceled.
  • Notice Printed [2] = This status is automatically assigned to an ABN when the ABN is printed. In practice, “ABN Printed” can function as either an initial or intermediate status, because staff can print a copy of the ABN before or after presenting the form to the patient.
  • Notice Triggered [1] = This status is automatically assigned to new ABN forms. Indicates an ABN warning has been prompted. The order/procedure will NOT be able to be signed when the ABN is in this state.
Compliance & Safety, Hemostasis/Coagulation

Update: Platelet Aggregation Studies Scheduling

Effective immediately, platelet aggregation testing will require a pathology consult prior to scheduling for testing performed at Corewell Health Reference Laboratory West, Grand Rapids. This consult request must be completed prior to scheduling the patient for testing.

After consultation the testing may be ordered and scheduled.

As a reminder testing is performed for scheduled patients Monday – Thursday from 7:30 am-9:30 am at the 35 Michigan Street Laboratory. Patients should be resting, fasting, non-smoking, and should not be pregnant. Patients should avoid taking any prescription or over the counter medications known to affect platelet function for ten (10) days to two (2) weeks prior to the test. Click for a list of medications with known anti-platelet effects.

Test Information:

 

Compliance & Safety, Education & Training, General Information

Reminder: Thin Prep Collection

With the August changes to STI testing Corewell Health Reference Laboratory West has seen an influx of incorrect orders. As a reminder, not all STI testing can be performed off of a Thin Prep® specimen. The STI Panel includes four different tests: Gonorrhea PCR, Chlamydia PCR, Trichomonas PCR and Mycoplasma Geniltalium PCR (Mgen). Unlike the other testing, Mgen cannot be added on to the Thin Prep® container.

 

If an STI Panel is ordered and the only specimen that is collected is a Thin Prep®, laboratory staff will independently cancel the STI panel and reorder the three tests that are able to be completed off of the specimen that is submitted. If an Mgen test is still needed, please submit a separate urine or swabbed collection using the Alinity -M collection kit.

Compliance & Safety, General Information, Test Utilization

Lipid & Vitamin D policy for Medicare patients

Traditional Medicare insured patients who have a Lipid Panel or Vitamin D 25 ordered more than once per 12 months are not covered due to medical necessity.*

If testing is indicated, you will need to provide an appropriately executed Advance Beneficiary Notice (ABN) for Corewell Health Southeast Laboratories and Advance Beneficiary Notice for Corewell Health Southwest and West Laboratories signed by the patient indicating they would like testing and understand they may be financially responsible for payment (ABN: Option 1). ABN must be submitted with specimen.

For testing ordered inside this frequency range without an ABN, Corewell Health will implement an automatic cancellation. Continue Reading

Compliance & Safety, Education & Training, General Information

IMPORTANT: Lipid Testing Changes

Effective Monday, September 16, 2024 all Corewell Health ambulatory offices will see an increase in Frequency Advance Beneficiary Notices (ABN) when ordering Lipids. This ensures compliance with Medicare requirements. ABNs serve as an indication to ordering physicians and APPs that the order has a stipulation for coverage and that Medicare may not reimburse for services; the patient will need to acknowledge potential financial responsibility. Having this completed ABN on file allows Corewell Health to provide and bill for services.

Specific to lipid frequency ABNs:

• Screening: Medicare covers testing once every 5 years. Per CMS, lipid testing in asymptomatic individuals is considered screening regardless of the presence of other risk factors such as family history, tobacco use, etc.
• Monitoring: Medicare covers testing once annually for monitoring the lifestyle and/or pharmaceutical treatment of lipid disorders. If more frequent testing is medically necessary after initiation of therapy, Medicare will cover up to six total cholesterol or LDL labs in the first year of therapy.

Lab will collect any ABNs needed if not collected prior to patient collection at our Patient Service Centers. If collection occurs in the office, be sure to follow the process: Ambulatory Clinical – Completing the Advance Beneficiary Notice (ABN) from the Epic Education Team SharePoint page. Any Medicare patient specimen submitted for lipid panel testing without an ABN will NOT be tested by the laboratory.

For more information on the CMS requirements for lipid testing, please review the NCD – Lipid Testing (190.23) (cms.gov)